Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pomalidomide-amino-PEG3-NH2 is a synthesized compound comprising a conjugation between the E3 ligase ligand linker and Pomalidomide, a cereblon ligand. Designed for application in PROTAC technology, it incorporates a linker that enables effective binding with targeted proteins.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder |
Description | Pomalidomide-amino-PEG3-NH2 is a synthesized compound comprising a conjugation between the E3 ligase ligand linker and Pomalidomide, a cereblon ligand. Designed for application in PROTAC technology, it incorporates a linker that enables effective binding with targeted proteins. |
In vitro | PROTACs are compounds comprising two distinct ligands connected by a linker: one ligand targets an E3 ubiquitin ligase, while the other targets a specific protein. Utilizing the intracellular ubiquitin-proteasome system, PROTACs selectively degrade target proteins [2]. |
Alias | Pomalidomide-amino-PEG3-NH2 |
Molecular Weight | 462.459 |
Formula | C21H26N4O8 |
Cas No. | 2380273-74-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.